[Federal Register: November 23, 1998 (Volume 63, Number 225)]
[Notices]               
[Page 64726]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr23no98-121]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

 
National Cancer Institute; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Novel Immunotherapeutic Strategies for the Prevention and 
Treatment of Cancer.
    Date: December 9-11, 1998.
    Time: 7:00 PM to 11:00 AM.
    Agenda: To review and evaluate grant applications.
    Place: Hotel La Jolla, 7955 La Jolla Shores Drive, La Jolla, CA 
92037.
    Contact Person: Florence E. Farber, PhD., Executive Secretary, 
Office of Advisory Activities, Division of Extramural Activities, 
National Cancer Institute, National Institutes of Health, 6130 
Executive Boulevard, EPN 609, Rockville, MD 20892, 301/496-2378.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)
    Dated: November 12, 1998.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 98-31160 Filed 11-20-98; 8:45 am]
BILLING CODE 4140-01-M